Natural Capsules Limited

BSE:524654 Voorraadrapport

Marktkapitalisatie: ₹3.1b

Natural Capsules Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Natural Capsules has been growing earnings at an average annual rate of 26.7%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 23.5% per year. Natural Capsules's return on equity is 1.9%, and it has net margins of 2.8%.

Belangrijke informatie

26.7%

Groei van de winst

19.6%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie17.5%
Inkomstengroei23.5%
Rendement op eigen vermogen1.9%
Nettomarge2.8%
Volgende winstupdate12 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Natural Capsules geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

BSE:524654 Opbrengsten, kosten en inkomsten (INR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 241,569431340
31 Mar 241,554561290
31 Dec 231,528721200
30 Sep 231,5831131170
30 Jun 231,6591511150
31 Mar 231,7241841120
31 Dec 221,7632091100
30 Sep 221,6841971080
30 Jun 221,536170990
31 Mar 221,3511391010
31 Dec 211,166104990
30 Sep 211,00879940
30 Jun 2189265890
31 Mar 2179569830
31 Dec 2072054790
30 Sep 2066740780
30 Jun 2063530760
31 Mar 206169750
31 Dec 1961717800
30 Sep 1960717760
30 Jun 1959518750
31 Mar 1959819740
31 Dec 1855918690
30 Sep 1854721680
30 Jun 1857822640
31 Mar 1854811670
31 Dec 175854560
30 Sep 175843560
30 Jun 175352590
31 Mar 175366620
31 Dec 1654211670
30 Sep 1654412680
30 Jun 1657725660
31 Mar 1662143660
31 Dec 156434815410
30 Sep 156725915110
30 Jun 156715714910
31 Mar 1567356600
31 Dec 14669531248
30 Sep 14638531218
30 Jun 14613491198
31 Mar 14585461188
31 Dec 13558651007

Kwaliteitswinsten: 524654 has high quality earnings.

Groeiende winstmarge: 524654's current net profit margins (2.8%) are lower than last year (9.1%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 524654's earnings have grown significantly by 26.7% per year over the past 5 years.

Versnelling van de groei: 524654's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Winst versus industrie: 524654 had negative earnings growth (-71.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (19.1%).

Rendement op eigen vermogen

Hoge ROE: 524654's Return on Equity (1.9%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y